Undetectable High Sensitivity Cardiac Troponin T Level in the Emergency Department and Risk of Myocardial Infarction Nadia Bandstein, MD; Rickard Ljung,

Slides:



Advertisements
Similar presentations
Population Trends in the Incidence and Outcomes of Acute Myocardial Infarction Robert W. Yeh, MD MSc Massachusetts General Hospital Alan S. Go, MD Kaiser.
Advertisements

Early assessment of myocardial injury by joint measurement of TnT-hs and Copeptin (1) J. Teixeira, (2) P. Wotquenne, (2) V. D’Orio, (3) D. Gruson, (1)
Tobias Reichlin, W. Hochholzer, C. Stelzig, K. Laule, M. Potocki, K
Copeptin and high sensitive Troponins Discussion of NEJM publications on sensitive Troponins BRAHMS GmbH, August 2010.
1 Sixty-Four-Slice Computed Tomography of the Coronary Arteries: Cost-Effectiveness Analysis of Patients Presenting to the ED with Low Risk Chest Pain.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence May–June 2010.
Troponin Use in A&E/EAU
Management of Acute Myocardial Infarction Minimal Acceptable vs Optimal Care Hussien H. Rizk, MD Cairo University.
Morbidity & Mortality: 2012 Chart Book on Cardiovascular, Lung, and
Anterior Depressions Angiographic and Clinical Outcomes Among Patients with Acute Coronary Syndromes Presenting with Anterior ST-Segment Depressions C.
How can new diagnostic methods contribute in healthcare? What are doctors looking for? Better support in their clinical decision makings, which includes:
Accurate and Rapid Diagnosis of Myocardial Infarction Using a High-Sensitivity Troponin I 1-Hour Algorithm Johannes Tobias Neumann1, Nils Arne Sörensen1,
Biochemical Markers for Diagnosis of Myocardial Infarction Cardiovascular Block Medical Biochemistry Course Dr. Reem M. Sallam, MD, PhD.
ACUTE CORONARY SYNDROMES Part I. Definition Acute coronary syndrome (ACS) describes a spectrum of clinical conditions ranging from ST segment elevation.
Community Outreach to Reduce Disparities in Cardiovascular & Diabetes Morbidity & Mortality in the South Bronx Michael Alderman, MD Michelle Johnson, MD,
Absolute and Relative Kinetic Changes of High-Sensitivity Cardiac Troponin T in Acute Coronary Syndrome and in Patients with Increased Troponin in the.
Journal Club Optimizing Early Rule-Out Strategies for Acute Myocardial Infarction: Utility of 1-Hour Copeptin P. Hillinger, R. Twerenbold, C. Jaeger, K.
Coronary Heart Disease (CHD) László Tornóci Inst. Pathophysiology Semmelweis University.
Implementation of a Sensitive Troponin I Assay and Risk of Recurrent Myocardial Infarction and Death in Patients With Suspected Acute Coronary Syndrome.
Cost Conscious Project: How Many Troponins Does It Take? Rola Khedraki.
Which troponin assay to choose? Clinical performances of troponin T and troponin I assays Per Venge, MD PhD Professor Department of Medical Sciences Uppsala.
Rapid assessment of chest pain Dr Phil Avery Prince Philip Hospital Hywel Dda Health Board PCCS 18 th May 2011.
Troponin By Julie Moore C Dt204/2.
The JUPITER Trial Reference Ridker PM. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008;359:2195–2207.
Date of download: 6/24/2016 Copyright © The American College of Cardiology. All rights reserved. From: Implications of Introducing High-Sensitivity Cardiac.
Cost Containment: Use of Troponin testing in the Inpatient Wards Setting Neal Kaushal, R2 DSR2, May 2013.
Perioperative Myocardial Infarctions The silent and neglected Killer
PJ Devereaux, MD, PhD McMaster University
Josephine Mak Waikato Cardiothoracic Unit Journal Club
Atherosclerotic Cardiovascular Heart Disease in Women
Women and Cardiovascular Disease
Incidence of Undetectable, Measurable, and Increased Cardiac Troponin I Concentrations Above the 99th Percentile Using a High-Sensitivity Versus a Contemporary.
Evaluation of CT Coronary Angiography (CTCA) and Cardiac Magnetic Resonance (CMR) in patients presenting with Acute Chest Pain (ACP) at A&E Background.
A Clinical profile of patients enrolled in the Pakistan ACS registry
Myocardial Injury after Noncardiac Surgery and Association with Short Term Mortality Wilton A van Klei Anesthesiologist and acting chair Department Anesthesiology,
Risk Stratification of Chest Pain: Best Practices
. Troponin limit of detection plus cardiac risk stratification scores for the exclusion of myocardial infarction and 30-day adverse cardiac events in ED.
HEART PATHWAY Brian O’Neal, MD
Evaluation of Patients with chest pain Admitted under General Medicine; Has clinical judgment being taken over by serial troponins? Dr. Samantha Herath.
Cocaine-Related Chest Pain: The Year After
The European Society of Cardiology Presented by Dr. Bo Lagerqvist
Patient populations by study group figure 10
Tobias Reichlin, M. D. , Willibald Hochholzer, M. D
Diagnostic characteristics and prognoses of primary-care patients referred for clinical exercise testing: a prospective observational study Nilsson G1,
Cost Effective Use of Troponin to Rule Out Acute Coronary Syndrome
ASSENT-3 PLUS 1,639 patients with STEMI Treatment Group A
The IDEAL Study Reference
Improved Outcomes in Patients with Non-ST-Elevation Myocardial Infarction during 20 Years are Related to Implementation of Evidence-based Treatments –
Cardiac Troponin.
Cardiac Biomarkers.
Identifying Patients Suitable for Discharge After a Single-Presentation High-Sensitivity Troponin Result: A Comparison of Five Established Risk Scores.
Chapter 1 Benefits and Risks Associated with Physical Activity
The Hypertension in the Very Elderly Trial (HYVET)
Section A: Introduction
European Heart Association Journal 2007 April
Learning Objectives Current Practices in Ruling Out AMI.
Advancing Acute Coronary Syndrome Assessment:
Prognostic Value of Undetectable hs Troponin T in Suspected Acute Coronary Syndrome  Mehrshad Vafaie, MD, Anna Slagman, VD, MSc, Martin Möckel, MD, PhD,
Division of Cardiovascular Diseases No relevant author disclosures
Significance of Periprocedural Myocardial Infarctions in Percutaneous Coronary Interventions A New Look at an Old Topic Abhiram Prasad, MD, FRCP, FESC,
Undetectable High Sensitivity Cardiac Troponin T Level in the Emergency Department and Risk of Myocardial Infarction Nadia Bandstein, MD; Rickard Ljung,
What oral antiplatelet therapy would you choose?
Potassium levels and risk of in-hospital arrhythmias and mortality in patients admitted with suspected acute coronary syndrome  Jonas Faxén, Hong Xu,
China PEACE risk estimation tool for in-hospital death from acute myocardial infarction: an early risk classification tree for decisions about fibrinolytic.
Ongoing statin therapy at hospitalization for acute myocardial infarction. Learnings for general practitioners. Ghena Shabana Specialist in Family Medicine.
HILLSBOROUGH COUNTY SHERIFF’S DEPARTMENT
Update on better disease diagnosis
ST-segment elevation myocardial infarction in China from 2001 to 2011 (the China PEACE-Retrospective Acute Myocardial Infarction Study): a retrospective.
Pre-hospital prediction of transmural myocardial infarction and the need of acute coronary reperfusion by an artificial neural network compared to real-time.
Study flow chart and diagnosis at discharge from ED
Presentation transcript:

Undetectable High Sensitivity Cardiac Troponin T Level in the Emergency Department and Risk of Myocardial Infarction Nadia Bandstein, MD; Rickard Ljung, MD, PhD; Magnus Johansson, MD, PhD; Martin Holzmann, MD, PhD. Department of Emergency Medicine Karolinska University Hospital and Karolinska Institute Stockholm, Sweden Late Breaking Clinical Trial, ACC.14, Washington

Disclosure information No conflicts of interest. Nadia Bandstein, M.D.

Background Chest pain is one of the most common reasons for seeking medical attention in Emergency Departments (ED) with an estimated 15–20 million visits each year in Europe and the U.S. Only 10-20% of patients of patients hospitalized for chest pain are diagnosed with MI Unnecessary admissions are a burden for health care providers Nadia Bandstein, M.D.

Background The cornerstone of diagnosing MI is the ECG and biomarkers indicating myocardial damage, commonly cardiac troponins Recently high-sensitivity cardiac troponin assays have been introduced in clinical practice They are able to detect minimally increased levels of troponins in the blood several hours before older generations of troponin assays Repeated measurements of hs-cTnT may not be necessary Nadia Bandstein, M.D.

Hypothesis All patients with chest pain, who have an undetectable high-sensitivity cardiac troponin T (< 5 ng/l), and an ECG without signs of ischemia, may be discharged directly from the emergency department (ED), since their risk of MI within 30 days is minimal. Nadia Bandstein, M.D.

Setting and Study population All patients, > 25 years of age, who came to the emergency department at the Karolinska University Hospital in Stockholm, Sweden, with a principal complaint of chest pain, and at least one hs-cTnT level analyzed, during December 10, 2010 to December 31, 2012 were included Nadia Bandstein

Methods High sensitivity cardiac troponin T (hs-cTnT) Elecsys 2010 system (Roche Diagnostics GmbH, Mannheim, Germany) Detection limit of 2 ng/l, 99th-percentile cutoff point of 14 ng/l Coefficient of variation was <10% at 13 ng/l   Nadia Bandstein, M.D.

Methods Exposure A first hs-cTnT < 5 ng/L (undetectable) in the ED, in combination with an ECG without significant ST-elevation or depression All ECGs for patients with undetectable hs-cTnT and MI were evaluated by two external senior cardiologists blinded for the study protocol Nadia Bandstein, M.D.

Methods Outcome Primary outcome: Fatal or non-fatal MI within 30 days Secondary outomes: MI at 180, and 365 days all-cause mortality at 30, 180, and 365 days Nadia Bandstein, M.D.

Study population n=14 636 < 5 ng/L 61% 5 – 14 ng/L > 14 ng/L 18% 330 000 ED visits / 2 years n=14 636 (4,4%) Hs-cTnT < 5 ng/L 61% Admitted 21% Discharged 79% 5 – 14 ng/L 44% 56% > 14 ng/L 18% 82% Study period 2010 - 2012 Age > 25, chest pain, hs-cTnT analyzed

Results patient characteristics   High-sensitivity Cardiac Troponin T level (ng/L) All patients <5 5-14 >14 Number of patients 14 636 8 907 3 150 2 579 Percent of cohort 100 61 22 18 Age (y) 55 47 63 71 Female sex, (%) 48 53 41 37 Diabetes (%) 10 5 14 21 Prior MI (%) 9 4 39 Prior Stroke (%) 2 7 13 Prior CHF (%) 6 1 8

Patients with undetectable hs-cTnT and MI within 30 d. No ECG changes n=15 NSTEMI n=11 Maximum hs-cTnT < 30 ng/l, n=6 40–100 ng/l, n=3 >100 ng/l, n=2 Coronary Angiography STEMI n=4 ECG changes n=24

Timing of hs-cTnT level analysis in MI patients with undetectable hs-cTnT and ECG without ischemia The first hs-cTnT level was measured within 2 h of the onset of symptoms in 11 (73%) patients, between 2 to 3 hours in 2 (13%) patients, and >3 h after the onset of symptoms in 2 (13%) patients. Namn Efternamn 24 februari 2019

Risk of Myocardial Infarction   High-Sensitivity Cardiac Troponin T level (ng/L) <5 5-14 >14 Myocardial infarction 30 days Number of events 15 97 676 Negative pred. val. 99,8 (99,7-99,9) 96,9 (96,3-97,5) 73,8 (72,1-75,5) 365 days  54  134  753 99,4 (99,2-99,5) 95,7 (95,0-96,5) 70,8 (69,0-72,6)

Risk of death in patients with undetectable hs-cTnT There were 2 deaths within 30 days The NPV for death was 100% (99.9-100) At 1 year of follow-up there were 38 deaths, of whom 32 were caused by cancer and 2 were cardiovascular Nadia Bandstein, M.D.

Discharge diagnosis in patients with undetectable hs-cTnT who were admitted 77% of admitted patients were discharge the same or the next day, In patients with undetectable hs-cTnT 50% had a discharge diagnosis of unspecific chest pain, the second most common diagnosis was atrial fibrillation (6%), the third most common diagnosis was angina pectoris (5%) Nadia Bandstein, M.D.

Clinical Implications Unnecessary admissions may be avoided May help diminish overcrowding of the ED Saving time for the patient and the doctor Nadia Bandstein, M.D.

Conclusion A first hs-cTnT level of <5 ng/l and no signs of ischemia on ECG ruled out MI with nearly 100% accuracy regardless of prior disease, timing of measurement of the hs-cTnT level, age, sex, or other risk factors for MI, The negative predictive value for death associated with an undetectable hs-cTnT and an ECG without signs of ischemia was 100%, Only in our hospital this simple strategy may prevent 500 to 1000 unnecessary hospitalizations per year Nadia Bandstein, M.D.

Thank you ACC.14 Nadia Bandstein, M.D.